APL, a model disease for cancer therapies?
- 29 October 2001
- journal article
- review article
- Published by Springer Nature in Oncogene
- Vol. 20 (49) , 7136-7139
- https://doi.org/10.1038/sj.onc.1204851
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- P53 and PML: new partners in tumor suppressionTrends in Cell Biology, 2001
- Two Critical Hits for Promyelocytic LeukemiaMolecular Cell, 2000
- RAR-independent RXR signaling induces t(15;17) leukemia cell maturationThe EMBO Journal, 1999
- Pml Is Critical for Nd10 Formation and Recruits the Pml-Interacting Protein Daxx to This Nuclear Structure When Modified by Sumo-1The Journal of cell biology, 1999
- Combined Arsenic and Retinoic Acid Treatment Enhances Differentiation and Apoptosis in Arsenic-Resistant NB4 CellsBlood, 1998
- Fusion proteins of the retinoic acid receptor-α recruit histone deacetylase in promyelocytic leukaemiaNature, 1998
- Nuclear bodies (NBs): A newly “rediscovered” organelleExperimental Cell Research, 1992
- The PML-RARα fusion mRNA generated by the t(15;17) translocation in acute promyelocytic leukemia encodes a functionally altered RARCell, 1991
- Use of all-trans retinoic acid in the treatment of acute promyelocytic leukemiaBlood, 1988
- Book noticesBritish Journal of Surgery, 1960